SB
Savita Bansal
About Savita Bansal
Data last updated:
Savita Bansal is a Director at Seraphic Pharma Formulations Private Limited (since 2017). The company operates in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Seraphic Pharma Formulations Private Limited U74999RJ2017PTC057181 | Director | 01 Apr 2017 | 2017 | Active |
Board colleagues of Savita Bansal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Ganeriwal | 07716471 | Seraphic Pharma Formulations Private Limited | Director |
| Dinesh Kumar Biyani | 01876593 | Seraphic Pharma Formulations Private Limited | Director |
| Pragati Ganeriwal | 07716511 | Seraphic Pharma Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Savita Bansal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savita Bansal
Savita Bansal currently holds 1 directorship: Seraphic Pharma Formulations Private Limited (Director, since 01 Apr 2017).
Savita Bansal was first appointed on 01 Apr 2017 as Director at Seraphic Pharma Formulations Private Limited.
The current boards of Savita Bansal's companies include Amit Kumar Ganeriwal (Seraphic Pharma Formulations Private Limited), Dinesh Kumar Biyani (Seraphic Pharma Formulations Private Limited), Pragati Ganeriwal (Seraphic Pharma Formulations Private Limited).